adenine has been researched along with Hyperparathyroidism, Secondary in 8 studies
Hyperparathyroidism, Secondary: Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the controls of bone and mineral metabolism, leading to various BONE DISEASES, such as RENAL OSTEODYSTROPHY.
Excerpt | Relevance | Reference |
---|---|---|
" Here, we established a rat model with secondary hyperparathyroidism (SHPT) and bone disease induced by adenine and a high phosphorous diet and analyzed the skeletal characteristics." | 3.88 | A rat model of SHPT with bone abnormalities in CKD induced by adenine and a high phosphorus diet. ( Chen, Q; Liu, BC; Lv, LL; Ni, HF; Ni, LH; Song, KY; Tang, RN; Wang, B; Wang, FM; Wang, LT; Wu, M, 2018) |
"After adenine dosing, significant hyperphosphatemia, hypocalcemia and secondary hyperparathyroidism (2HPT) were observed during the experimental period of 15 weeks." | 3.75 | Vascular calcification and secondary hyperparathyroidism of severe chronic kidney disease and its relation to serum phosphate and calcium levels. ( Fujimori, A; Fukushima, S; Itoh, H; Mizukami, K; Nara, H; Okada, M; Sanagi, M; Takakura, K; Terai, K, 2009) |
"Tenofovir disoproxil fumarate is the first-line antiviral therapy for chronic viral hepatitis B, but long-term use is associated with renal failure and hypophosphatemic osteomalacia." | 2.82 | Tenofovir-induced osteopenia and hyperparathyroidism: A case report and literature review. ( Li, L; Ma, W; Wei, D; Ye, P; Zeng, J, 2022) |
"Secondary hyperparathyroidism is characterized by increased parathyroid hormone (PTH) mRNA stability that leads to increased PTH mRNA and serum PTH levels." | 1.35 | Regulation of PTH mRNA stability by the calcimimetic R568 and the phosphorus binder lanthanum carbonate in CKD. ( Ben-Dov, IZ; Naveh-Many, T; Nechama, M; Silver, J, 2009) |
"At week 9, renal failure resolved with improvement in the hyperparathyroid state." | 1.35 | Uraemic hyperparathyroidism causes a reversible inflammatory process of aortic valve calcification in rats. ( Abedat, S; Beeri, R; Ben-Dov, IZ; Danenberg, HD; Lotan, C; Meir, K; Planer, D; Shuvy, M; Sosna, J, 2008) |
"Adenine-treated rats showed marked elevations of serum phosphorus, PTH and FGF23 levels associated with parathyroid hyperplasia and aortic calcification." | 1.33 | [Effects of intermittent treatment with sevelamer hydrochloride on parathyroid hyperplasia and vascular calcification in rats with chronic kidney disease]. ( Abe, M; Kobayashi, N; Miyata, S; Nagano, N; Wada, M; Wakita, S, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
Authors | Studies |
---|---|
Sato, H | 3 |
Goto, M | 3 |
Nishimura, G | 3 |
Morimoto, N | 3 |
Tokushima, H | 3 |
Horii, Y | 3 |
Takahashi, N | 3 |
Zeng, J | 1 |
Ye, P | 1 |
Wei, D | 1 |
Li, L | 1 |
Ma, W | 1 |
Ni, LH | 1 |
Tang, RN | 1 |
Lv, LL | 1 |
Wu, M | 1 |
Wang, B | 1 |
Wang, FM | 1 |
Ni, HF | 1 |
Song, KY | 1 |
Wang, LT | 1 |
Chen, Q | 1 |
Liu, BC | 1 |
Nechama, M | 1 |
Ben-Dov, IZ | 3 |
Silver, J | 2 |
Naveh-Many, T | 2 |
Terai, K | 1 |
Nara, H | 1 |
Takakura, K | 1 |
Mizukami, K | 1 |
Sanagi, M | 1 |
Fukushima, S | 1 |
Fujimori, A | 1 |
Itoh, H | 1 |
Okada, M | 1 |
Galitzer, H | 1 |
Nagano, N | 1 |
Miyata, S | 1 |
Abe, M | 1 |
Wakita, S | 1 |
Kobayashi, N | 1 |
Wada, M | 1 |
Shuvy, M | 1 |
Abedat, S | 1 |
Beeri, R | 1 |
Danenberg, HD | 1 |
Planer, D | 1 |
Meir, K | 1 |
Sosna, J | 1 |
Lotan, C | 1 |
1 review available for adenine and Hyperparathyroidism, Secondary
Article | Year |
---|---|
Tenofovir-induced osteopenia and hyperparathyroidism: A case report and literature review.
Topics: Adenine; Bone Diseases, Metabolic; Calcium; Humans; Hyperparathyroidism, Primary; Hyperparathyroidis | 2022 |
7 other studies available for adenine and Hyperparathyroidism, Secondary